Embla Medical
27.25 DKK
-1.27 %
Less than 1K followers
EMBLA
NASDAQ Copenhagen
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Embla Medical
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 4,577.8 | 3,810.9 | 4,721.4 | 4,992.5 | 5,304.8 | 6,131.0 | 5,905.0 |
| growth-% | -16.8 % | 23.9 % | 5.7 % | 6.3 % | 15.6 % | -3.7 % | |
| EBITDA | 731.2 | 562.9 | 978.6 | 793.4 | 940.6 | 1,212.9 | 1,182.2 |
| EBIT | 651.9 | 171.3 | 639.3 | 450.4 | 603.5 | 811.5 | 796.7 |
| Profit before taxes | 602.2 | 77.0 | 569.2 | 390.2 | 513.2 | 649.5 | 686.3 |
| Net income | 459.4 | 48.0 | 431.3 | 300.2 | 397.0 | 494.6 | 531.9 |
| EPS | 0.99 | 0.08 | 0.99 | 0.72 | 0.95 | 1.16 | 1.25 |
| Dividend | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | 15.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | 16.0 % | 14.8 % | 20.7 % | 15.9 % | 17.7 % | 19.8 % | 20.0 % |
| EBIT-% | 14.2 % | 4.5 % | 13.5 % | 9.0 % | 11.4 % | 13.2 % | 13.5 % |
| ROE | 12.1 % | 1.4 % | 10.5 % | 6.8 % | 8.3 % | 8.8 % | 9.3 % |
| ROI | 6.3 % | 0.7 % | 5.3 % | 3.3 % | 4.2 % | 4.5 % | 4.8 % |